Our CEO, Martin Lehr, will present at the Piper Sandler 36th Annual Healthcare Conference on December 4th at 11:00am ET. #PiperSandler, #oncology
Context Therapeutics的动态
最相关的动态
-
Learn "How to Build a Successful Phase I Clinical Trials Unit", with customized tips from Drs Razelle Kurzrock and David Hong. https://loom.ly/UziFTXE #phase1 #oncology
要查看或添加评论,请登录
-
-
Explore the benefits of early phase centralized image storage, often referred to as Collect & Hold. Here are 4 key takeaways from our #oncology webinar. Watch the full video here: https://lnkd.in/gzbXcuzW #MERITCRO #YourClinicalEndpointExpert #oncologyresearch #clinicalresearch #imagingsolutions
要查看或添加评论,请登录
-
Not finding the right patients for a trial can be a major setback. Delays in early phase can hamper momentum and offer competitors an opportunity. This breakdown of the early-phase #oncology landscape shows how the right planning can accelerate your path to success. https://hubs.ly/Q02VyQMF0
要查看或添加评论,请登录
-
-
**Poster Session Highlights**? ?? The science is clear—Oncotype? DX is delivering actionable insights! Visit our poster sessions for the latest findings and stop by booth 943 to discuss further. #Research #SABCS2024 #OncotypeDx #SABCS24 #Oncology
要查看或添加评论,请登录
-
-
Join my colleagues from Inizio Medical for a webinar on June 27th where we will dive into the most talked-about topics from #ASCO24, provide in-depth analysis, and highlight key takeaways - this is not to be missed! Learn more and register here: https://lnkd.in/e3pr9aEG #MRX #ResearchPartnership #Oncology #Webinar
要查看或添加评论,请登录
-
-
Check out this head-to head comparison of the humanized NSG-SGM3 model vs Taconic's NOG-Exl model at U Penn! If you are working in oncology research and have been experiencing difficulties due to early myeloid hyperactivation syndrome (MCH) in your in-vivo models, I would love to connect with you and discuss how Taconic can support your studies long-term!
New paper compares the humanized NSG-SGM3 and NOG-EXL showing better outcomes and more translatable results for glioblastoma work. Read more: https://hubs.li/Q02PpxY10 #oncology
要查看或添加评论,请登录
-
-
**Poster Session Highlights**? ?? The science is clear—Oncotype? DX is delivering actionable insights! Visit our poster sessions for the latest findings and stop by booth 943 to discuss further. #Research #SABCS2024 #OncotypeDx #SABCS24 #Oncology
要查看或添加评论,请登录
-
-
Lin, Chengyu, M.D., Associate Medical Director at MERIT, outlines a common challenge when implementing reader monitoring plans, and how that challenge is addressed. Watch this short video clip to learn more! #MERITCRO #YourClinicalEndpointExpert #oncology #clinicaltrials #clinicalresearch
Short Video: Common Challenge with Reader Monitoring Plans and How to Address
要查看或添加评论,请登录
-
In early-phase oncology clinical trials, patients are at the heart of every breakthrough. Discover how innovative trial designs are improving patient outcomes and driving the future of cancer treatment with the new article from Precision For Medicine.
Not finding the right patients for a trial can be a major setback. Delays in early phase can hamper momentum and offer competitors an opportunity. This breakdown of the early-phase #oncology landscape shows how the right planning can accelerate your path to success. https://hubs.ly/Q02VyQMF0
要查看或添加评论,请登录
-